Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · Real-Time Price · USD

Compare

30.22

-0.10 (-0.33%)

At close: Feb 11, 2026, 4:00 PM EST

29.77

-0.45 (-1.49%)

After-hours: Feb 11, 2026, 5:28 PM EST

Travere Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-88.54	-321.55	-111.4	-278.48	-180.09	-169.43
Depreciation & Amortization	54.7	43.56	38.53	20.72	12.75	24.58
Other Amortization	1.73	1.73	1.72	1.62	11.24	10.48
Asset Writedown & Restructuring Costs	-	65.21	-	-	-	97.13
Loss (Gain) From Sale of Investments	-4.54	-4.54	-7.46	-0.7	2.01	-
Stock-Based Compensation	42.62	36.91	44.25	38.14	29.57	23.61
Other Operating Activities	1.77	11.68	-265.52	-43.02	-32.48	-3.07
Change in Accounts Receivable	-57.63	-6	-11.26	-1.06	0.85	2.3
Change in Inventory	3.55	-3.77	-39.42	-1.21	0.12	-5.07
Change in Accounts Payable	-5.32	-17.56	24.76	2.06	2.47	-6.04
Change in Unearned Revenue	-3.37	-6.12	-15.78	-12.93	38.3	-
Change in Income Taxes	-0.04	-0.04	-0.04	-0.37	17.1	-15.75
Change in Other Net Operating Assets	3.55	-29.53	16.26	14.39	21.94	-1.49
Operating Cash Flow	-58.61	-237.48	-280.02	-186.29	-14.79	-42.74
Capital Expenditures	-0.29	-	-	-	-5.1	-6.77
Cash Acquisitions	-	-	-	-	-	-95.28
Sale (Purchase) of Intangibles	-48.56	-101.21	-41.59	-28.37	-19.05	-17.8
Investment in Securities	101.25	200.58	-109.37	-3.4	-113.47	58.52
Other Investing Activities	0.03	-0.04	206.73	-0.79	-	-
Investing Cash Flow	52.42	99.33	55.78	-32.55	-137.62	-61.33
Long-Term Debt Issued	-	-	-	316.25	-	-
Long-Term Debt Repaid	-	-	-	-211.32	-	-
Net Debt Issued (Repaid)	-68.9	-	-	104.93	-	-
Issuance of Common Stock	149.98	141.52	197.6	27.11	239.89	137.46
Other Financing Activities	-2.1	-2.1	21.15	-14.46	-8.2	-9.75
Financing Cash Flow	78.97	139.42	218.75	117.57	231.68	127.71
Foreign Exchange Rate Adjustments	1.74	-0.91	1.98	-2.79	1.71	-1.31
Net Cash Flow	74.52	0.36	-3.51	-104.07	80.98	22.34
Free Cash Flow	-58.91	-237.48	-280.02	-186.29	-19.89	-49.51
Free Cash Flow Margin	-13.52%	-101.84%	-192.80%	-170.19%	-15.09%	-24.96%
Free Cash Flow Per Share	-0.67	-3.01	-3.77	-2.92	-0.33	-1.04
Cash Interest Paid	8.84	8.84	8.84	10.16	7.33	6.9
Cash Income Tax Paid	0.45	0.45	0.58	1	-16.42	-3.37
Levered Free Cash Flow	-69.02	-228.53	-178.11	-163.35	-60.79	-46.34
Unlevered Free Cash Flow	-63.7	-223.27	-172.74	-158.08	-59.73	-44.91
Change in Working Capital	-59.26	-63.02	-25.48	0.88	80.78	-26.04

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q